These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 28821853)
1. Visceral adiposity index is strongly associated with hyperuricemia independently of metabolic health and obesity phenotypes. Dong H; Xu Y; Zhang X; Tian S Sci Rep; 2017 Aug; 7(1):8822. PubMed ID: 28821853 [TBL] [Abstract][Full Text] [Related]
2. Positively increased visceral adiposity index in hyperuricemia free of metabolic syndrome. Gu D; Ding Y; Zhao Y; Miao S; Qu Q Lipids Health Dis; 2018 May; 17(1):101. PubMed ID: 29734946 [TBL] [Abstract][Full Text] [Related]
3. Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype. Du T; Yu X; Zhang J; Sun X Acta Diabetol; 2015 Oct; 52(5):855-63. PubMed ID: 25690647 [TBL] [Abstract][Full Text] [Related]
4. Visceral adiposity index predicts the conversion of metabolically healthy obesity to an unhealthy phenotype. Kang YM; Jung CH; Cho YK; Jang JE; Hwang JY; Kim EH; Lee WJ; Park JY; Kim HK PLoS One; 2017; 12(6):e0179635. PubMed ID: 28644850 [TBL] [Abstract][Full Text] [Related]
5. The Impact of Blood Pressure and Visceral Adiposity on the Association of Serum Uric Acid With Albuminuria in Adults Without Full Metabolic Syndrome. Krajcoviechova A; Tremblay J; Wohlfahrt P; Bruthans J; Tahir MR; Hamet P; Cifkova R Am J Hypertens; 2016 Dec; 29(12):1335-1342. PubMed ID: 27565787 [TBL] [Abstract][Full Text] [Related]
6. Visceral adiposity index is a better predictor of unhealthy metabolic phenotype than traditional adiposity measures: results from a population-based study. Ferreira FG; Juvanhol LL; da Silva DCG; Longo GZ Public Health Nutr; 2019 Jun; 22(9):1545-1554. PubMed ID: 30520411 [TBL] [Abstract][Full Text] [Related]
7. Sex-Specific Differences in the Association of Metabolically Healthy Obesity With Hyperuricemia and a Network Perspective in Analyzing Factors Related to Hyperuricemia. Tian S; Liu Y; Feng A; Zhang S Front Endocrinol (Lausanne); 2020; 11():573452. PubMed ID: 33123092 [TBL] [Abstract][Full Text] [Related]
8. Body adiposity index, lipid accumulation product, and cardiometabolic index reveal the contribution of adiposity phenotypes in the risk of hyperuricemia among Chinese rural population. Wang H; Sun Y; Wang S; Qian H; Jia P; Chen Y; Li Z; Zhang L Clin Rheumatol; 2018 Aug; 37(8):2221-2231. PubMed ID: 29770928 [TBL] [Abstract][Full Text] [Related]
9. Visceral adiposity index (VAI), a powerful predictor of incident hypertension in prehypertensives. Zhang Z; Shi D; Zhang Q; Wang S; Liu K; Meng Q; Chen X Intern Emerg Med; 2018 Jun; 13(4):509-516. PubMed ID: 29569088 [TBL] [Abstract][Full Text] [Related]
10. Visceral Adiposity Index and Lipid Accumulation Product Index: Two Alternate Body Indices to Identify Chronic Kidney Disease among the Rural Population in Northeast China. Dai D; Chang Y; Chen Y; Chen S; Yu S; Guo X; Sun Y Int J Environ Res Public Health; 2016 Dec; 13(12):. PubMed ID: 27983609 [TBL] [Abstract][Full Text] [Related]
11. Association between Visceral Adiposity Index and Hyperuricemia among Steelworkers: The Moderating Effects of Drinking Tea. Huang X; Zhong Z; He J; Them S; Chen M; Liu A; Tan H; Wen S; Deng J Nutrients; 2024 Sep; 16(18):. PubMed ID: 39339821 [TBL] [Abstract][Full Text] [Related]
12. Derivation and validation of a new visceral adiposity index for predicting visceral obesity and cardiometabolic risk in a Korean population. Oh SK; Cho AR; Kwon YJ; Lee HS; Lee JW PLoS One; 2018; 13(9):e0203787. PubMed ID: 30212516 [TBL] [Abstract][Full Text] [Related]
13. Cumulative burden of abnormal visceral adiposity index and its components on the risk of hyperuricemia. Tian X; Chen S; Xu Q; Zhang Y; Wu S; Wang A; Luo Y Nutr Metab Cardiovasc Dis; 2023 Feb; 33(2):340-349. PubMed ID: 36641317 [TBL] [Abstract][Full Text] [Related]
14. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis. Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189 [TBL] [Abstract][Full Text] [Related]
15. Association between hyperuricemia and nontraditional adiposity indices. Liu XZ; Li HH; Huang S; Zhao DB Clin Rheumatol; 2019 Apr; 38(4):1055-1062. PubMed ID: 30498873 [TBL] [Abstract][Full Text] [Related]
16. Visceral adipose accumulation increased the risk of hyperuricemia among middle-aged and elderly adults: a population-based study. Huang X; Jiang X; Wang L; Chen L; Wu Y; Gao P; Hua F J Transl Med; 2019 Oct; 17(1):341. PubMed ID: 31601236 [TBL] [Abstract][Full Text] [Related]
18. Visceral adiposity index performed better than traditional adiposity indicators in predicting unhealthy metabolic phenotype among Chinese children and adolescents. Dong Y; Bai L; Cai R; Zhou J; Ding W Sci Rep; 2021 Dec; 11(1):23850. PubMed ID: 34903825 [TBL] [Abstract][Full Text] [Related]
19. Visceral Adiposity Index Is Associated with Pre-Diabetes and Type 2 Diabetes Mellitus in Chinese Adults Aged 20-50. Liu PJ; Ma F; Lou HP; Chen Y Ann Nutr Metab; 2016; 68(4):235-43. PubMed ID: 27161795 [TBL] [Abstract][Full Text] [Related]
20. Nontraditional risk factors for cardiovascular disease and visceral adiposity index among different body size phenotypes. Du T; Zhang J; Yuan G; Zhang M; Zhou X; Liu Z; Sun X; Yu X Nutr Metab Cardiovasc Dis; 2015 Jan; 25(1):100-7. PubMed ID: 25159728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]